IBBvsRAYS
iShares Biotechnology ETF against Global X Solar ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBB | RAYS | |
|---|---|---|
| Expense ratio | 0.45% | 0.50% |
| Assets | $10.7B | $7286.40T |
| Net flow, 1 month | +$656M | — |
| Net flow, 1 year | +$2.2B | — |
| Return, YTD | +22.0% | — |
| Return, 1 year | +38.7% | — |
| Avg daily volume | 1.5M | — |
| Holdings | 221 | 49 |
| Listed | Feb 5, 2001 | Sep 8, 2021 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS